SOPHiA GENETICS
SOPHiA GENETICS develops AI-driven technology to democratize data-driven medicine, converting complex genetic data into actionable insights for better disease diagnosis and treatment.
Classification
Profile
Funding
Funding details not yet available.
Transforms complex genomic data into actionable insights using AI to democratize data-driven medicine and improve patient outcomes globally.
Healthcare providers and institutions seeking to elevate standards of care through advanced diagnostic tools and precision medicine.
SaaS and subscription services
Direct Sales Force - Dedicated account managers for large hospital systems and biopharma partners · Strategic Partnerships - Alliances with sequencing instrument vendors (e.g., Illumina, Thermo Fisher) and health-IT platforms to embed SOPHi · Digital Marketing & Thought Leadership - Webinars, whitepapers, and a robust content hub (blog, case studie
Illumina, Varionyx, leading hospital networks
R&D, platform development, data acquisition and curation, sales and marketing
AI-driven technology platforms capable of converting complex data into actionable clinical insights for disease diagnosis.
Developing AI technology to convert complex data into actionable insights and pioneering global standards for data-driven medicine.
Dedicated Account Management - High-touch support for enterprise contracts (custom integration, training, compliance assistance) · Technical Support & 24/7 Helpdesk - SLA-backed assistance for pipeline failures or data-privacy queries · Community-Driven Knowledge Base - Peer-reviewed variant interpretations and best-practice guides that keep users
Competes with other genomic data interpretation platforms like Tempus, Exact Sciences, and commercial variants of Illumina's BaseSpace. Differentiated by its broad, multi-cancer focus and cloud-native AI approach.
Breaking barriers to care location or circumstance and enabling better disease diagnosis and treatment through data democratization.
No investors recorded yet.